Showing results (211-220 of 261) with videos related to
Sort By:
Pageof 27
Cytotherapy|December 13, 2016
Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipientsSarah Nikiforow, Shuli Li, Karen Snow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib StudyAlexander M Lesokhin, Stephen M Ansell, Philippe Armand, et al.Blood Advances|June 14, 2018
Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCLChelsea C Pinnix, Andrea K Ng, Bouthaina S Dabaja, et al.Blood|May 5, 2017
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHDBradley M Haverkos, Diana Abbott, Mehdi Hamadani, et al.Heart (British Cardiac Society)|November 9, 2022
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancerCho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, et al.Blood Advances|September 1, 2019
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and childrenJennifer S Whangbo, Haesook T Kim, Nikola Mirkovic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2019
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell LymphomaPhilippe Armand, Scott Rodig, Vladimir Melnichenko, et al.Blood|June 2, 2020
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S Davids, Haesook T Kim, Caitlin Costello, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2018
A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple MyelomaJacob P Laubach, Chia-Jen Liu, Noopur S Raje, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2019
Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with NivolumabAiping Chen, Fatima-Zohra Mokrane, Lawrence H Schwartz, et al.Pageof 27